Recent Publication: Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson’s Disease Psychosis
Reducing falls and fractures remains an essential clinical goal in managing older adults with Parkinson’s disease psychosis (PDP) in long-term care and nursing home (LTC/NH) settings. Falls and fractures in this population are associated with significant morbidity, reduced quality of life, and increased healthcare costs. A recent retrospective study by Rajagopalan et al., published in a peer-reviewed journal, analyzed Medicare data to assess the risk of falls and fractures among LTC residents with PDP who were receiving continuous monotherapy with pimavanserin (PIM) compared to other atypical antipsychotics (AAPs) and quetiapine (QUE).